<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>FDA CDER Offer Letter: FAERS Pharmacovigilance Dashboard</title>

  <style>
    :root{
       [oai_citation:4â€¡04_task.html](sediment://file_00000000993872069f30dba965734462)     --fda-navy:#0b1f3a;
      --fda-sky:#eaf3ff;
      --ink:#0b1020;
      --muted:#4b5563;
      --paper:#ffffff;
      --border:#e6e9f2;
      --bg:#f4f6fb;
      --accent:#2b8cc4;
      --warn:#b58800;
    }

    *{box-sizing:border-box}

    body{
      margin:0;
      background:var(--bg);
      color:var(--ink);
      font:15px/1.55 system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif;
      padding:24px;
    }

    .page{
      width:210mm;
      max-width:100%;
      margin:0 auto;
      background:var(--paper);
      border:1px solid var(--border);
      box-shadow:0 10px 30px rgba(10,20,60,.08);
    }

    .masthead{
      background:linear-gradient(0deg, var(--fda-navy), var(--fda-blue));
      color:#fff;
      padding:16px 40px;
      display:flex;
      align-items:center;
      justify-content:space-between;
      gap:16px;
      flex-wrap:wrap;
      border-bottom:4px solid var(--accent);
    }

    .brand{
      display:flex;
      align-items:center;
      gap:12px;
      min-width:360px;
    }

    .brand img{
      height:34px;
      width:auto;
      display:block;
      filter: drop-shadow(0 2px 6px rgba(0,0,0,.18));
    }

    .org{
      line-height:1.2;
    }

    .org .name{
      font-size:15px;
      font-weight:820;
      color:#fff;
      letter-spacing:.2px;
    }

    .org .dept{
      font-size:12.5px;
      color:rgba(255,255,255,.86);
      margin-top:2px;
    }

    .contact{
      text-align:right;
      font-size:12.5px;
      color:rgba(255,255,255,.86);
    }

    .contact strong{
      color:#fff;
      font-weight:850;
    }

    main{
      padding:32px 40px 26px;
      overflow-wrap:anywhere;
    }

    .meta{
      display:flex;
      justify-content:space-between;
      gap:16px;
      flex-wrap:wrap;
      margin-bottom:18px;
      font-size:13px;
      color:var(--muted);
    }

    .meta .block{min-width:260px}
    .meta .block div{margin:2px 0}

    .subject{
      margin:18px 0 14px;
      padding:12px 14px;
      border:1px solid var(--border);
      border-left:4px solid var(--fda-blue);
      background:var(--fda-sky);
      font-weight:860;
      color:var(--ink);
    }

    h2{
      font-size:13.5px;
      margin:18px 0 8px;
      color:var(--fda-navy);
      letter-spacing:.2px;
      text-transform:uppercase;
    }

    p{margin:10px 0}
    ul{margin:8px 0 10px 18px}
    li{margin:6px 0}

    .callout{
      margin:16px 0;
      padding:14px 14px;
      border:1px solid var(--border);
      border-left:4px solid var(--warn);
      background:#fffdf2;
      color:var(--ink);
    }

    .kpi-grid{
      display:grid;
      grid-template-columns:1fr 1fr;
      gap:10px 16px;
      margin:10px 0 6px;
      padding:12px 14px;
      border:1px solid var(--border);
      background:#fcfdff;
    }

    .kpi-grid div{
      font-size:13px;
      color:var(--muted);
    }

    .kpi-grid strong{
      color:var(--ink);
      font-weight:860;
    }

    .signature{
      margin-top:26px;
      display:flex;
      align-items:flex-end;
      justify-content:space-between;
      gap:20px;
      flex-wrap:wrap;
    }

    .sigline{
      margin-top:8px;
      border-top:1px solid var(--border);
      padding-top:10px;
      min-width:360px;
    }

    .signature-img{
      display:block;
      max-width:110px;
      height:auto;
      margin:4px 0 6px;
    }

    .signame{font-weight:880}
    .sigtitle{color:var(--muted); font-size:13px; margin-top:2px}

    footer{
      padding:14px 40px 22px;
      border-top:1px solid var(--border);
      display:flex;
      justify-content:space-between;
      gap:12px;
      flex-wrap:wrap;
      color:var(--muted);
      font-size:12px;
    }

    .disclaimer{max-width:720px}

    .pill{
      display:inline-block;
      font-size:12px;
      padding:2px 9px;
      border-radius:999px;
      border:1px solid rgba(0,94,162,0.25);
      background: rgba(0,94,162,0.06);
      color: var(--fda-blue);
      margin-right:6px;
      margin-bottom:6px;
      font-weight:650;
    }

    @page{
      size:A4;
      margin:15mm;
    }

    @media print{
      body{
        background:#fff !important;
        padding:0 !important;
        margin:0 !important;
      }
      .page{
        box-shadow:none !important;
        border:0 !important;
        width:auto !important;
        max-width:none !important;
      }
      *{
        -webkit-print-color-adjust: exact;
        print-color-adjust: exact;
      }
      header, footer, .signature, .callout{
        break-inside: avoid;
        page-break-inside: avoid;
      }
    }
  </style>
</head>

<body>
  <div class="page" role="document" aria-label="Letter">
    <header class="masthead">
      <div class="brand">
        <img src="assets/fda-logo.png" alt="U.S. Food and Drug Administration (FDA)" />
        <div class="org">
          <div class="name">U.S. Food and Drug Administration</div>
          <div class="dept">Center for Drug Evaluation and Research (CDER), Office of Surveillance and Epidemiology</div>
        </div>
      </div>

      <div class="contact">
        <div><strong>10903 New Hampshire Avenue</strong></div>
        <div>Silver Spring, MD 20993</div>
        <div>drug.safety.analytics@fda.gov</div>
        <div>+1 (301) 000 0000</div>
      </div>
    </header>

    <main>
      <div class="meta">
        <div class="block">
          <div><strong>To:</strong> Analyst Placement Cohort</div>
          <div><strong>From:</strong> Pharmacovigilance Analytics Unit</div>
          <div><strong>Reference:</strong> CDER-OSE-FAERS-SURV-2026</div>
        </div>
        <div class="block" style="text-align:right">
          <div><strong>Date:</strong> <span id="date"></span></div>
          <div><strong>Engagement:</strong> Safety monitoring dashboard + technical note</div>
          <div><strong>Data source:</strong> FAERS (public extracts)</div>
        </div>
      </div>

      <div class="subject">
        Subject: Offer of Engagement, FAERS Adverse Drug Reaction Surveillance Dashboard
      </div>

      <p>
        The Center for Drug Evaluation and Research (CDER) is commissioning an internal training deliverable to support
        the interpretation of post marketing adverse event reports. Your team will build a decision support dashboard
        that enables non technical reviewers to explore reporting patterns and potential safety signals in a structured way.
      </p>

      <p>
        This engagement uses public extracts of the FDA Adverse Event Reporting System (FAERS). These reports are submitted by
        healthcare professionals, consumers, and manufacturers. They are valuable for signal detection, but they do not confirm
        that a drug caused an event. Your work must communicate that distinction clearly.
      </p>

      <div class="callout">
        <strong>Analytical standard:</strong>
        This tool is designed for surveillance and triage. You should describe patterns, associations, and reporting changes.
        You must avoid causal claims. You must document how you define cohorts, how you handle missingness, and how you treat
        multi drug reports. If you introduce any scoring or flagging, it must be described as a simple prioritisation aid.
      </div>

      <h2>data provided</h2>
      <p>
        You will be provided with a curated extract derived from public FAERS releases, structured to be analysis ready for this project.
        The underlying source material is based on the FAERS Quarterly Data Extract.
      </p>

      <div>
        <span class="pill">FAERS quarterly extract</span>
        <span class="pill">Adverse reactions</span>
        <span class="pill">Drug roles</span>
        <span class="pill">Outcomes</span>
        <span class="pill">Demographics</span>
      </div>

      <p><strong>What one row represents:</strong> one adverse event report, linked to one or more suspect drugs and one or more reported reactions.</p>

      <h2>project objectives</h2>
      <ul>
        <li>Enable reviewers to explore reporting frequency over time for selected medicines</li>
        <li>Summarise the adverse reaction profile for each selected medicine in a consistent way</li>
        <li>Provide demographic and outcome context to support responsible interpretation</li>
        <li>Support comparison across multiple drugs, including within the same therapeutic area</li>
        <li>Produce a brief technical note that explains limitations and appropriate interpretation</li>
      </ul>

      <h2>required dashboard modules</h2>

      <h2>module 1: reporting volume and trends</h2>
      <ul>
        <li><strong>Views:</strong> time series of report counts, month or quarter aggregation, optional rolling average</li>
        <li><strong>Questions:</strong> Are there spikes or sustained increases? Do patterns differ between drugs? Are trends stable across time windows?</li>
      </ul>

      <h2>module 2: reaction profile</h2>
      <ul>
        <li><strong>Views:</strong> top reported reactions for selected drug(s), reaction category grouping if available, comparison mode</li>
        <li><strong>Questions:</strong> Which reactions dominate reporting? Are reaction profiles similar across drugs? Are rare but serious reactions present?</li>
      </ul>

      <h2>module 3: seriousness and outcomes</h2>
      <ul>
        <li><strong>Views:</strong> outcome distribution (hospitalisation, death, life threatening, disability), seriousness split by time or subgroup</li>
        <li><strong>Questions:</strong> Does the mix of outcomes change over time? Are severe outcomes concentrated in specific subgroups?</li>
      </ul>

      <h2>module 4: population context</h2>
      <ul>
        <li><strong>Views:</strong> age band and sex distributions, optional filters for reporter type and country if available</li>
        <li><strong>Questions:</strong> Are reports concentrated in older populations? Are patterns consistent across sexes? Are there data gaps that affect interpretation?</li>
      </ul>

      <div class="kpi-grid" aria-label="Suggested headline metrics">
        <div><strong>Suggested KPI:</strong> Total reports for selected drug(s) in chosen period</div>
        <div><strong>Suggested KPI:</strong> Proportion of reports flagged as serious</div>
        <div><strong>Suggested KPI:</strong> Most common reaction term or category</div>
        <div><strong>Suggested KPI:</strong> Change in reporting rate vs prior period</div>
      </div>

      <h2>implementation requirements</h2>
      <ul>
        <li>Include filters for drug selection and time range at minimum</li>
        <li>All outputs must use one consistently filtered dataset to avoid mismatched numbers</li>
        <li>Provide at least three charts and one summary table</li>
        <li>Use plain language labels suitable for non technical reviewers</li>
        <li>Include a visible disclaimer panel about interpretation and non causality</li>
      </ul>

      <h2>stretch goals</h2>
      <ul>
        <li>Add comparison between two drugs or a drug class view</li>
        <li>Add a download button for filtered data and a download button for a key figure</li>
      </ul>

      <h2>deliverables</h2>
      <ul>
        <li><strong>Interactive dashboard:</strong> Shiny app suitable for a stakeholder walk through</li>
        <li><strong>Technical note:</strong> one to two pages describing data provenance, cleaning assumptions, limitations, and interpretation guidance</li>
      </ul>

      <div class="signature">
        <div class="sigline">
          <div class="sigtitle">Lead, Pharmacovigilance Analytics Unit, CDER OSE</div>
          <img class="signature-img" src="assets/signature.png" alt="Signature" />
          <div style="font-size:12.5px;color:var(--muted);margin-top:6px;">
            For questions about scope and deliverables, contact: drug.safety.analytics@fda.gov
          </div>
        </div>

        <div style="min-width:240px; text-align:right; color:var(--muted); font-size:12.5px;">
          <div><strong>Requested start:</strong> Immediate</div>
          <div><strong>Requested duration:</strong> Final project period</div>
          <div><strong>Output format:</strong> Dashboard + technical note</div>
        </div>
      </div>
    </main>

    <footer>
      <div>
        CDER OSE | Pharmacovigilance Analytics
      </div>
    </footer>
  </div>

  <script>
    (function(){
      const el = document.getElementById("date");
      if(!el) return;
      const d = new Date();
      const opts = { year: "numeric", month: "long", day: "numeric" };
      el.textContent = d.toLocaleDateString(undefined, opts);
    })();
  </script>
</body>
</html>
